| 2024-03-27 | +1.55 % |
- The article discusses Hologic, Inc. (NASDAQ:HOLX) stock going up by 1.55% last night, attributed to various changes in hedge fund and institutional investor positions, including Whittier Trust Co. selling a portion of its holdings in Hologic and other similar transactions, as well as positive analyst ratings and quarterly earnings results exceeding expectations.
- The article discusses Artemis Investment Management LLP lowering its position in shares of Hologic, Inc. (NASDAQ:HOLX) by 42.8% during the fourth quarter, along with other institutional investors making changes, resulting in a 1.55% increase in HOLX stock. HOLX stock went up due to various institutional investors increasing their holdings in the company, such as Macquarie Group Ltd., Norges Bank, Arrowstreet Capital Limited Partnership, Qube Research & Technologies Ltd, and Prudential Financial Inc., among others, and positive analyst ratings.
|
| 2024-03-26 | +0.69 % |
|
| 2024-03-22 | -0.34 % |
- The article provides updates on various stocks and market activities, mentioning that Hologic (HOLX) stock was down by -0.34%. The stock might have dropped due to broader market trends, company-specific news, industry factors, or a combination of these reasons.
- The article discusses various stock market updates and movements of different companies, including Hologic (HOLX) stock which was down by -0.34%, with the overall stock market showing mixed results. Hologic's stock might have gone down due to specific factors affecting the company's performance or overall market conditions, such as industry trends, company news, economic indicators, or investor sentiment.
- The article discusses Hologic, Inc. (NASDAQ:HOLX) stock, which was down -0.34% last night, with analysts recommending a hold rating and a twelve-month price objective of $86.89, citing recent earnings data, including surpassing EPS estimates in February, and insider selling of shares as factors potentially influencing the stock price.
|
| 2024-03-21 | +0.64 % |
|
| 2024-03-20 | -1.66 % |
|
| 2024-03-19 | -0.05 % |
|
| 2024-03-14 | -1.3 % |
|
| 2024-03-13 | +0.91 % |
|
| 2024-03-07 | +1.49 % |
|
| 2024-03-05 | -1.13 % |
|
| 2024-03-01 | -0.2 % |
|
| 2024-02-29 | -0.43 % |
- Summary: Elanco Animal Health Incorporated has shown meaningful operational progress and engagement, with the stock price up by 39% over the past year, despite Ancora Holdings Group, LLC nominating director candidates, leading to a -0.43% decrease in Hologic (HOLX) stock.
Reason for Hologic (HOLX) stock going down: The decrease in Hologic (HOLX) stock could be due to general market conditions, the company's own financial results, or broader industry trends affecting healthcare stocks.
- The article discusses Hologic, Inc. (NASDAQ:HOLX) stock being down 0.43% and receiving an average "Hold" rating from analysts due to mixed buy and hold recommendations, with a 1-year price target averaging $86.89, and mentions recent insider selling activities. The stock price decline could be attributed to a combination of analyst ratings, market conditions, profit-taking, and individual stock transactions.
|
| 2024-02-28 | -1.65 % |
|
| 2024-02-27 | +0.74 % |
|
| 2024-02-26 | -1.76 % |
- The article provides an announcement from Hologic, Inc. regarding their upcoming participation in investor conferences, and the stock of Hologic (HOLX) went down by -1.76% due to various market conditions, investor sentiments, industry developments, or specific company news.
- The article discusses how institutional investors, such as Northern Trust Corp, have been reducing their positions in Hologic, Inc. (NASDAQ:HOLX), contributing to a 1.76% decrease in the stock value; this decline in stock value can be attributed to such significant investors selling off portions of their holdings in the medical equipment provider.
- The article discusses Envestnet Asset Management Inc.'s reduced stake in Hologic, Inc. and various other institutional investors' actions, causing the Hologic (HOLX) stock to go down by -1.76%, with its share price opening at $76.15, due to recent selling of shares.
|
| 2024-02-23 | +0.36 % |
|
| 2024-02-22 | +0.08 % |
|
| 2024-02-21 | +1.66 % |
|
| 2024-02-16 | -0.01 % |
|
| 2024-02-15 | +0.89 % |
|
| 2024-02-13 | -1.07 % |
|
| 2024-02-09 | +0.01 % |
|
| 2024-02-08 | -0.57 % |
|
| 2024-02-07 | -0.43 % |
|
| 2024-02-06 | +2.96 % |
|
| 2024-02-05 | -0.55 % |
|
| 2024-02-02 | -2.65 % |
- The article discusses the recent decline in Hologic, Inc. (NASDAQ:HOLX) stock, which decreased by 2.65%. The decline may be attributed to Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increasing its stake in Hologic by 8.0% during the third quarter, resulting in concerns among investors about the dilution of shares.
- The article compares medical companies Epigenomics and Exact Sciences based on analyst recommendations, profitability, institutional ownership, risk, valuation, earnings, and dividends, with Exact Sciences being favored due to higher institutional ownership and a lower price-to-earnings ratio. It does not mention why Hologic (HOLX) stock specifically went down.
|
| 2024-02-01 | -0.04 % |
|
| 2024-01-31 | -0.65 % |
|
| 2024-01-29 | +0.77 % |
|
| 2024-01-26 | +0.36 % |
|
| 2024-01-23 | +0.9 % |
|
| 2024-01-22 | +0.71 % |
|
| 2024-01-17 | +0.22 % |
|
| 2024-01-11 | +0.84 % |
|
| 2024-01-04 | +0.69 % |
|
| 2024-01-02 | +1.41 % |
|
| 2023-12-29 | +0.27 % |
- The article discusses the performance of the stock market in 2023, with the S&P 500 closing the year with a gain of over 24%. The Hologic (HOLX) stock went up by 0.27% on the last trading day of the year. The stock market's gains were driven by major companies like Apple, Microsoft, and Amazon. The broader market rally in the later part of the year helped smaller companies recover their losses from the previous year. The stock market is betting that the Federal Reserve will achieve a "soft landing" by cutting interest rates, which is expected to support the market's momentum in 2024.
- The Hologic (HOLX) stock went up by 0.27% last night due to the overall positive sentiment in the market, driven by factors such as easing inflation, a resilient economy, and the prospect of lower interest rates in the future.
- The article mentions that the S&P 500 closed out 2023 with a gain of more than 24 percent and the Dow finished near a record high, driven by easing inflation, a resilient economy, and the prospect of lower interest rates, which buoyed investors in the last two months of the year. It does not specifically mention why Hologic (HOLX) stock went up.
|
| 2023-12-26 | +0.1 % |
|
| 2023-12-22 | -0.04 % |
|
| 2023-12-20 | -1.17 % |
|
| 2023-12-15 | -0.15 % |
|
| 2023-12-13 | +1.47 % |
|
| 2023-11-30 | +0.99 % |
|
| 2023-11-27 | -0.29 % |
|
| 2023-11-24 | -0.61 % |
|
| 2023-11-21 | +0.01 % |
|
| 2023-11-10 | +7.34 % |
|
| 2023-11-09 | -1.57 % |
|
| 2023-11-02 | -0.12 % |
|
| 2023-10-31 | +1.32 % |
|
| 2023-10-27 | -1.03 % |
|
| 2023-10-26 | -1.25 % |
|
| 2023-10-23 | -0.37 % |
|
| 2023-10-13 | +1.59 % |
|
| 2023-10-12 | -2.18 % |
|
| 2023-10-11 | -1.92 % |
|
| 2023-10-10 | +0.74 % |
|
| 2023-09-29 | -0.93 % |
|
| 2023-09-28 | +1.17 % |
|